Delayed neuronal death in the gerbil hippocampal CA 1 sector occurs 48 to 72 hours after severe forebrain isch emia. DNA fragmentation is observed in the hippocampal CAl neurons at around that time. We show here that an inhibitor of proteolytic process of apoptosis, N-tosyl-L-phenylalanyl ehlo romethyl ketone (TPCK), protected hippocampal neuronal damage by inhibition of the DNA fragmentation in a dose-Abbreviations used: ICE, interleukin-ll3-converting enzyme; TDT, terminal deoxynucleotidyl transferase; TLCK, N-a-p-tosyl-L-lysinyl chloromethyl ketone; TPCK, N-tosyl-L-phenylalanyl chloromethyl ke tone; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP biotin in situ nick-end-labeling. 819 dependent manner and that TPCK induced an apoptosis regulating molecule, Bcl-2 protein, in the surviving neurons.
The specific DNA damage shown as internucleosomal DNA fragmentation is the most important evidence for apoptotic cell death, which is an active cell-deletion pro cess with protein synthesis (McConkey et aI., 1990; Wyl lie et aI., 1984) . Significant neuronal damage in the hip pocampus of the experimental model of severe forebrain ischemia is observed 48 to 72 hours after transient isch emia. The DNA fragmentation in the CAl neurons of the hippocampus has been considered as a key phenomenon for delayed neuronal death, which has been investigated by terminal deoxynucleotidyl transferase (TDT) mediated dUTP-biotin in situ nick-end labeling (TUNEL), gel electrophoresis, and electron microscope (Heron et aI., 1993; Iwai et aI., 1995; MacManus et aI., 1993; Nitatori et aI., 1995) .
Cytoplasmic proteases play a functional role in the pathway leading to apoptotic cell death (Chow et aI., 1995; Bruno et aI., 1992; Lazebnik et aI., 1994) . Some protease inhibitors have been reported to block apopto sis-associated internucleosomal DNA fragmentation. Among them, a strong apoptosis-inhibitory effect has focused on a serine protease inhibitor, N-tosyl-L phenylalanyl chloromethyl ketone (TPCK; Higuchi et aI., 1995; Lotem and Sachs, 1996) . This compound was reported to exert its proteinase inhibiting actions as an anti-inflammatory agent in vivo (Nakagawa et aI., 198 1; Hall et aI., 1980) .
In the current study, we evaluated the neuroprotective effect of TPCK, using intraperitoneal administration, on delayed neuronal death in the CA 1 sector of the gerbil hippocampus after severe forebrain ischemia.
MATERIALS AND METHODS

Induction of ischemia and drug treatment
Male Mongolian gerbils (Meriones ungiculatus), weighing 65 to 75 g, were subjected to severe forebrain ischemia. An esthesia was induced with halothane. The bilateral common carotid arteries were isolated through an anterior midcervical incision and occluded with microclips. After 5 minutes of fore-brain ischemia, the clips were removed, restoration of blood flow was visually confirmed, and then the wound was closed.
N-Tosyl-L-phenylalanyl chloromethyl ketone (Sigma Chemical
Co., St. Louis, MO, U.S.A.) at a dose of 100 mg/kg in O.OS% polysorbate 80 was injected intraperitoneally I hour before or I or 24 hours after the ischemic insult. In some gerbils, another serine protease inhibitor, N-u-p-tosyl-L-Iysinyl chloromethyl ketone (TLCK), at a dose of 100 mg/kg was also used in the same manner as TPCK. Rectal temperatures were maintained at 37° ± 0.3°C using a heating pad from the induction of anes thesia until 3 hours after ischemia. Sham-operated animals un derwent the same surgical manipulation without occlusion of the bilateral common carotid arteries. In the ischemic control group and sham-operated group, intraperitoneal administration of vehicle (O.OS% polysorbate 80) was performed. Six to eight animals per group were used for each experiment.
Histologic evaluation
Ninety-six hours after ischemic insult, animals were anes thetized with pentobarbital and perfused transcardially with sa line and then with buffered 10% formalin. Brains were re moved and processed for paraffin embedding. Five-micrometer coronal sections were cut at the level of the dorsal hippocampus and then used for hematoxylin and eosin staining, TUNEL, and Bcl-2 immunostaining. Neurons that had shrunken cell bodies were defined as damaged cells. Histologic analysis was per formed by a blinded observer and the average of right and left damaged cell numbers in a single section of dorsal hippocam pus was calculated for each gerbil as reported by Kirino et al. (1986) . The degree of hippocampal CAl damage was deter mined by measuring the number of damaged cells, as a pro portion of the entire cell number of CAl.
In situ labeling of DNA fragmentation TUNEL was performed as described previously (Hara et aI., 
Immunostaining for Bcl-2 protein
The Bcl-2 immunostaining was performed as described pre viously (Hara et aI., 1996a,b) . Briefly, the deparaffinized sec tions, which were cut serially to those used for hematoxylin and eosin staining, were heated and boiled for I minute by micro waving in citrate buffer. Anti-Bcl-2 antibody (N-19) was pur chased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, U.S.A.). Anti-Bcl-2 antibody, used at a dilution of I: 1000, was added to the slides and incubated overnight at 4°C. Expression of Bcl-2 protein was shown by the labeled streptavidin biotin method using the LSAB kit (DAKO) containing blocking re agent, biotinylated link antibody, and peroxidase-labeled strep tavidin reagents. The peroxidase binding sites were detected by J Cereb Blood Flow Metab, Vol. 18, No.8, 1998 staining with 3,3' -diaminobenzidine. Finally, counterstaining was performed using Mayer's hematoxylin.
RESULTS
Administration of TPCK (100 mg/kg) produced a marked neuroprotective effect when given I hour before or I hour after transient forebrain ischemia, Moreover, TPCK was effective in preventing neuronal damage after transient forebrain ischemia even when administered up to 24 hours after the ischemic insult ( Fig. la) , CA I neu ronal damage after transient forebrain ischemia was as sessed to determine the dose-response curve of TPCK administration I hour after ischemic insult at the doses of 25, 50, and 100 mg/kg ( Figure Ic) . More than 50 mg/kg of TPCK prevented neuronal damage after transient fore brain ischemia, whereas almost no neuronal preservation was observed at a dose of 25 mg/kg. Administration of 100 mg/kg TPCK was not fatal to the gerbil. Paralytic ileus was recognized in some gerbils at 96 hours after ischemic insult.
In the ischemic control group (vehicle administration), TUNEL exhibited a strong positive reaction (Fig. 2, a and c), indicating DNA fragmentation occurred exclu sively in damaged CAl neurons. Administration of TPCK (100 mg/kg) 1 hour before or 1 hour after isch emic insult lead to a remarkable decrease of the number of TUNEL-positive CAl neurons (Fig. 2, b and d) . Even in gerbils treated with TPCK (100 mg/kg) 24 hours after ischemia, significantly fewer TUNEL-positive cells were observed in the hippocampal CA 1 region than in that of vehicle-treated ischemic controls (Fig. I b) . The neuro protection by TPCK was always observed laterally in the CA I regions. Another serine protease inhibitor, TLCK (l 00 mg/kg, intraperitoneally) had no protective effect on CA I neurons after transient forebrain ischemia.
To assess the contribution of Bcl-2 protein to TPCK induced protection against ischemic insult, expression of Bcl-2 protein in preserved CA 1 neurons after ischemic insult was investigated. No immunoreactivity of Bcl-2 protein was detected in either CA 1 neurons of sham operated gerbils ( Fig. 2e ) or damaged CA 1 neurons of ischemic control animals (Fig. 2f ). Positive immunore activity of Bcl-2 was detected in many CA 1 neurons that were well-protected by TPCK treatment from ischemic insult (Fig. 2g) . Interestingly, all the Bcl-2-positive CAl neurons were observed in CA I layers that showed 0% to 10% TUNEL-positive rate, but not when the rate was above 10%. The Bcl-2-positive cells were observed in the preserved neurons by TPCK treatment, which were located laterally in the CA I regions.
DISCUSSION
In the present study, we demonstrated a protective effect of TPCK, which inhibits the proteolytic process of apoptosis, against postischemic neuronal damage in the gerbil hippocampus. It is possible that some neuropro tective agents are effective because of their hypothermic effect during or after ischemia. Intraischemic hypother mia prevents delayed neuronal death in the gerbil hippo campus (Welsh et aI., 1990; Iwai et aI., 1993) . However, the postischemic hypothermia is effective only if initi ated within 3 hours after ischemic insult (Carroll and Beek, 1992) . Therefore, we prevented hypothermia dur ing ischemia and for 3 hours after ischemia. Moreover, TPCK was effective in preventing neuronal damage after transient forebrain ischemia even when administered up to 24 hours after the ischemic insult. For these reasons, we considered that the protective mechanism of TPCK was not related to hypothermia.
Data from various experimental system support a role for proteolysis in apoptotic cell death. Interleukin-113converting enzyme (ICE)-like proteases have been de scribed to have a central role in proteolysis during ap optosis in HL-60 cells treated with cycloheximide for induction of apoptotic cell death (Lu and Mellgren, 1996) . Overexpression of ICE gene by cDNA transfec tion causes apoptosis in mammalian fibroblasts (Miura et aI., 1993) . Although ICE possesses a cysteine protease activity, it is different from TPCK-sensitive serine pro tease. In addition, TPCK does not inhibit the proteolytic activity of ICE-like proteases (Xue ct aI., 1996) . It has been suggested that apoptosis is associated with a mul tistep cascade of activated proteases that may act in a common pathway leading to apoptotic cell death (Lotem and Sachs, 1996) . In this proteolytic pathway, TPCK sensitive serine protease is considered to be associated with the final step for induction of internucleosomal DNA fragmentation (Yoshida et ai., 1996) . Our results revealed that another serine protease inhibitor, TLCK, has no inhibitory effect on apoptosis-related DNA frag mentation. Both TPCK and TLCK inhibit serine and cys teine proteases (Lotem and Sachs, 1996) . Chymotrypsin like proteases are targets of TPCK, whereas trypsinlike proteases are targets of TLCK (Higuchi et ai., 1995) . It is suggested that TPCK-sensitive proteases are associated with delayed neuronal death in gerbil hippocampal CAL Recent studies demonstrate that very low levels of BcI-2 protein, which has been shown to inhibit pro grammed cell death and promote neuronal survival (Chen et ai., 1997) , are found in rat (Krajewski et ai., 1995) and gerbil (Hara et al., 1996b; Shimazaki et ai., 1994) CAl neurons. Brief ischemia, which causes no neuronal damage, induces tolerance to subsequent isch emia and increases levels of BcI-2 protein (Shimazaki et aI., 1994) . In the present study, increased expression of Bcl-2 protein was detected in many CAl neurons that were protected from ischemic insult by TPCK adminis tration. The precise mechanistic relationship between cell survival and expression of BcI-2 protein in TPCK protected CA 1 neurons is currently unknown. However, the expression of BcI-2 protein in CA 1 neurons is con sidered closely related to the acquisition of resistance to ischemia-induced neuronal death, although the expres sion of BcI-2 protein is not recognized in all the cells.
Significant morphologic damage and TUNEL-positive DNA fragmentation in gerbil CAl neurons was observed only after 72 hours (Iwai et ai., 1995) . In the present study, TPCK was effective in preventing neuronal death (a and c) . In TPCK-treated (1 00 mg/kg, intraperi toneally, 1 hour after ischemia) isch emic gerbil (b and d), small numbers of TUNEL-positive cells are located in the restricted medial part of the CA 1 sector (inset in b). No immunostain ing for BcI-2 in the CA 1 sector from sham-operated (e) and ischemic con trol (f) gerbils is observed. However, in TPCK-treated ischemic gerbil, many neurons show strong immuno reactivity for Bcl-2 in their cytoplasm (g). The inset in g shows a high power field of Bcl-2 positive cells.
Scale bars indicate 1 mm (a and b) and 100 iJm (inset in b, and c-g).
TPeK, N-tosyl-L-phenylalanyl chlaro methyl ketone; TUNEL, terminal de oxynucleotidyl transferase-mediated dUTP biotin in situ nick-end labeling.
after transient forebrain ischemia in the gerbil when ad ministered up to 24 hours after ischemic insult. The first 24 hours after ischemic insult is considered to be a win dow of opportunity in which the biomolecular process leading to apoptotic cell death may be reversible. In con clusion, our results suggest that the prevention of apop to sis-related DNA fragmentation by TPCK, an inhibitor of the proteolytic process of apoptosis, may be an attrac tive therapeutic strategy in the prevention of neurode generation after stroke or cardiac arrest.
